ORTHALIGN ANNOUNCES CLINICAL MILESTONE HAVING PERFORMED 75,000 JOINT ARTHROPLASTY CASES

Thursday, February 15, 2018 2:18 PM UTC

Aliso Viejo, CA, Feb. 15, 2018 -- OrthAlign, Inc., a leading provider of orthopedic surgical navigation solutions, is proud to announce a clinical milestone with 75,000 navigation-assisted joint replacement surgeries. OrthAlign’s hand-held sensor-based technologies support a wide array of indications including total knee replacement, partial knee replacement and total hip replacement. The company’s flagship application, KneeAlign® for total knee replacement, provides both tibial and femoral intra-operative navigation in a simple, palm-sized, single-use device.

The KneeAlign application is compatible with all standard implant systems. The UniAlign™ application launched in early 2017 leveraging the clinical success of KneeAlign, and allowing for seamless transitions between partial and total knee replacement interventions. In 2017, the Company also introduced HipAlign® for total hip replacement into limited market evaluation. The HipAlign application provides cup navigation and measures changes in leg length and will be fully commercially available in 2018.

“We are thrilled to pass this significant milestone, building and servicing technologies that have assisted surgeons worldwide in completing more than seventy-five thousand successful arthroplasty surgeries,” said Eric Timko, Chairman and CEO of OrthAlign. “In ORs around the world, OrthAlign has become a trusted and reliable tool that our customers depend on to achieve their desired results.”

“What is remarkable about OrthAlign’s technology is that every post-operative result is consistent, every x-ray looks the same,” noted David Mayman, Co-Director of Computer Assisted Surgery at Hospital for Special Surgery. “I’m impressed by the rate of innovation happening at the company right now. The clinical advantage, along with the economics of the single-use disposable model, makes OrthAlign well poised for continued growth.”

ORTHALIGN, INC.

OrthAlign is a privately held medical device and technology company, developing advanced technologies that deliver healthier and more pain-free lifestyles to joint replacement patients, globally. We provide healthcare professionals with cutting edge, computer-assisted surgical tools that seamlessly and cost-effectively deliver vital data and clinical results to optimize outcomes for our patients. For more information regarding OrthAlign, please visit www.orthalign.com or contact Adam Simone ([email protected]).

Attachments:

A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/3bcf00e9-7096-400c-8f72-674ca85a457d

Adam Simone
OrthAlign
[email protected]

Editor's Picks

Breathing through your nose when you exercise may make your runs easier

Entrepreneurs are facing a mental health crisis — here's how to help them

Are fish oil supplements as healthy as we think? And is eating fish better?

Will AI kill our creativity? It could – if we don’t start to value and protect the traits that make us human

Does AI have a right to free speech? Only if it supports our right to free thought

How can I lower my cholesterol? Do supplements work? How about psyllium or probiotics?

Why we need to set limits on sperm donation

Aging with a healthy brain: How lifestyle changes could help prevent up to 40% of dementia cases

Seven techniques to avoid weight regain, approved by experts

ORTHALIGN ANNOUNCES CLINICAL MILESTONE HAVING PERFORMED 75,000 JOINT ARTHROPLASTY CASES

Editor's Picks

Welcome to EconoTimes